Supply Chain

As President-elect Donald Trump prepares to take office with a Republican-controlled Congress, major shifts in drug pricing policies are not expected, a new report by investment research firm Morningstar claims. However, the firm suggests ACA changes would likely focus on…

For Kelli McRory, no clinical product — from table paper to electrodes — is too small to warrant meticulous cost analysis when it comes to clinical spend management.

Amid controversial price hikes and surprising regulatory decisions, many aspects of the drug industry were scrutinized this past year.

 Titan Medical Industries named David McNally as a director and the new CEO of the Toronto-based robotic surgery company.

The majority of medical and surgical devices used to treat children are not cleared by the Food and Drug Administration for use in pediatric populations, according to a new report from the American Academy of Pediatrics.

While driverless cars are expected to decrease road fatalities, the technology may cause negative consequences for organ donation.

Amazon has set its sights high with plans for an airborne fulfillment center that would act as a launch pad for drones to deliver items to customers, reports CNBC.

Despite the technological advancements in inventory management systems, "phantom inventory" still threatens many supply chains, reports The Wall Street Journal.

While the emergence of new cancer medications increased survival rates in the last decade, therapeutic benefits vary greatly by drug,,according to a new study published in JAMA Oncology.

When planning for and implementing changes to your supply chain, it is important to include all stakeholders in the process, according to Tom Fox, a managing director at healthcare consulting firm Novia Strategies.